When a stock is up more than 160% in a year, it can be easy to think you missed the boat. However, that's not always the case, and when a high-flying stock like pharma darling Regeneron (REGN) pulls back, it can serve as a buying opportunity. In the following video, Brenton Flynn explains why investors shouldn't be shocked by the news that has this stock down about 5% today.
You're reading a free article with opinions that may differ from The Motley Fool's Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More
Should You Buy the Regeneron Sell-Off?
NASDAQ: REGN
Regeneron Pharmaceuticals

Is this an opportunity to invest in high-flying Regeneron?
Brenton Flynn has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Stocks Mentioned



*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Related Articles





Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.